Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gido Snaterse

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Endocrine Oncology (Bristol, England)|July 12, 2023
The role of 11-oxygenated androgens in prostate cancerGido Snaterse, Johannes Hofland, Bruno Lapauw
Endocrine-Related Cancer|September 20, 2017
Circulating steroid hormone variations throughout different stages of prostate cancerGido Snaterse, Jenny A Visser, Wiebke Arlt, et al.
Steroids|February 8, 2021
Validation of circulating steroid hormone measurements across different matrices by liquid chromatography-tandem mass spectrometryGido Snaterse, Lisanne F van Dessel, Angela E Taylor, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2026
Cytokine Dynamics Following Initiation of Gender-Affirming Hormone Therapy in Transgender SubjectsYaël Sertons, Sarah Collet, Jeroen Vervalcke, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 17, 2023
Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolitesGido Snaterse, Angela E Taylor, J Matthijs Moll, et al.
Diabetologia|August 10, 2015
Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in miceSander Kooijman, Yanan Wang, Edwin T Parlevliet, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2025
Age-Stratified Reference Ranges for Directly Measured Serum Free Testosterone in Community-Dwelling and Healthy MenJoeri Walravens, Gido Snaterse, Nick Narinx, et al.
Prostate Cancer and Prostatic Diseases|January 20, 2022
Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoidsGido Snaterse, Rosinda Mies, Wytske M van Weerden, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2024
SHBG Gene Polymorphisms and Their Influence on Serum SHBG, Total and Free Testosterone Concentrations in MenJoeri Walravens, Bas Sleumer, Michel J Vos, et al.
JCI Insight|May 11, 2021
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castrationGido Snaterse, Lisanne F van Dessel, Job van Riet, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Endocrine Oncology (Bristol, England)|July 12, 2023
The role of 11-oxygenated androgens in prostate cancerGido Snaterse, Johannes Hofland, Bruno Lapauw
Endocrine-Related Cancer|September 20, 2017
Circulating steroid hormone variations throughout different stages of prostate cancerGido Snaterse, Jenny A Visser, Wiebke Arlt, et al.
Steroids|February 8, 2021
Validation of circulating steroid hormone measurements across different matrices by liquid chromatography-tandem mass spectrometryGido Snaterse, Lisanne F van Dessel, Angela E Taylor, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2026
Cytokine Dynamics Following Initiation of Gender-Affirming Hormone Therapy in Transgender SubjectsYaël Sertons, Sarah Collet, Jeroen Vervalcke, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 17, 2023
Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolitesGido Snaterse, Angela E Taylor, J Matthijs Moll, et al.
Diabetologia|August 10, 2015
Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in miceSander Kooijman, Yanan Wang, Edwin T Parlevliet, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2025
Age-Stratified Reference Ranges for Directly Measured Serum Free Testosterone in Community-Dwelling and Healthy MenJoeri Walravens, Gido Snaterse, Nick Narinx, et al.
Prostate Cancer and Prostatic Diseases|January 20, 2022
Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoidsGido Snaterse, Rosinda Mies, Wytske M van Weerden, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2024
SHBG Gene Polymorphisms and Their Influence on Serum SHBG, Total and Free Testosterone Concentrations in MenJoeri Walravens, Bas Sleumer, Michel J Vos, et al.
JCI Insight|May 11, 2021
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castrationGido Snaterse, Lisanne F van Dessel, Job van Riet, et al.
Pageof 1